Royalty Pharma plc (RPRX)
NASDAQ: RPRX · Real-Time Price · USD
58.37
+0.40 (0.69%)
Aug 11, 2026, 10:07 AM EDT - Market open
Royalty Pharma Market Cap
Royalty Pharma has a market cap or net worth of $33.56 billion as of August 11, 2026. Its market cap has increased by 55.04% in one year.
Market Cap
33.56B
Enterprise Value
41.69B
1-Year Change
55.04%
Ranking
Category
Stock Price
$58.37
ChartMarket Cap Chart
Since June 16, 2020, Royalty Pharma's market cap has increased from $26.49B to $33.56B, an increase of 26.68%. That is a compound annual growth rate of 3.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 32.64B | 46.35% |
| Dec 31, 2025 | 22.30B | 48.40% |
| Dec 31, 2024 | 15.03B | -10.44% |
| Dec 29, 2023 | 16.78B | -30.07% |
| Dec 30, 2022 | 24.00B | -0.82% |
| Dec 31, 2021 | 24.20B | -20.37% |
| Dec 31, 2020 | 30.39B | 14.69% |
| Jun 16, 2020 | 26.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 55.41B |
| Revolution Medicines | 44.36B |
| BeOne Medicines AG | 40.82B |
| Insmed | 29.45B |
| Alnylam Pharmaceuticals | 29.03B |
| Roivant Sciences | 25.85B |
| Incyte | 24.63B |
| Moderna | 23.88B |